"You'll find limited and very limited permissions for specific pharmaceutical companies to work with that substance for study uses and for extremely precise narrowly prescribed healthcare applications," he described.In a press release to Day by day Hive, Health Canada suggested it would attain out to the companies concerned to “reiterate the real